Jun 04, 2020
Evolugate Takes Up the Challenge of Boosting Host Cells Used to Manufacture COVID-19 Vaccines
Jun 04, 2020
Intravacc Partners With Wageningen Bioveterinary Research and Utrecht University to Develop an Intranasal COVID-19 Vaccine
Jun 03, 2020
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected
May 29, 2020
Global Vaccines market is Expected to Reach $81.27 Billion by 2027 - Latest Market Research Report by Stratistics MRC
May 20, 2020
Bharat Biotech, Thomas Jefferson University pursue a promising vaccine candidate against COVID-19
May 20, 2020
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
May 19, 2020
PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
May 18, 2020
Infectious Vaccines Partnering 2014 to 2020: Deal Trends, Players and Financials
May 14, 2020
Global COVID-19 Vaccines Pipeline 2020: 150 Organizations' Vaccines for COVID-19, SARS and MERS
May 14, 2020
Veterinary Vaccines Market Worth $11.3 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
May 12, 2020
NEOVII to Develop a Novel Vaccine for COVID-19 in an Exclusive Partnership With Tel Aviv University
May 12, 2020
GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccines
May 11, 2020
INOVIO Reports First Quarter 2020 Financial Results; Provides Business Update
May 11, 2020
Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France
May 11, 2020
Soligenix Announces Publication of Correlates of Immune Protection for the RiVax® Ricin Toxin Vaccine
May 07, 2020
Therapeutic Vaccines Industry Analysis and Forecast 2015-2025 (COVID-19 Adjusted)
May 05, 2020
NYU Langone Among First Centers to Enroll Patients in US Clinical Trial for COVID-19 mRNA Vaccine
May 04, 2020
BiondVax Announces Upcoming Expiration of Public Warrants
Apr 30, 2020
INOVIO Expands Manufacturing of COVID-19 DNA Vaccine INO-4800 With New Funding from CEPI
Apr 28, 2020
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June